Trade

with

Abaxis Inc
(NASDAQ: ABAX)
AdChoices
51.11
+1.75
+3.55%
After Hours :
51.11
0.00
0.00%

Open

49.55

Previous Close

49.36

Volume (Avg)

451.05k (201.23k)

Day's Range

49.44-52.50

52Wk Range

32.11-53.98

Market Cap.

1.11B

Dividend Rate (Yield )

0.40 (0.41%)

Beta

0.96

Shares Outstanding

22.52M

P/E Ratio (EPS)

70.92 (0.69)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Diagnostics & Research
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 171.87M

    • Net Income

    • 14.18M

    • Market Cap.

    • 1.11B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 8.90

    • PEG (Price/Earnings Growth) Ratio

    • 2.91

    • Beta

    • 0.96

    • Forward P/E

    • 50.76

    • Price/Sales

    • 6.33

    • Price/Book Value

    • 5.64

    • Price/Cash flow

    • 33.33

      • EBITDA

      • 28.23M

      • Return on Capital %

      • 7.30

      • Return on Equity %

      • 8.32

      • Return on Assets %

      • 7.30

      • Book Value/Share

      • 8.75

      • Shares Outstanding

      • 22.52M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.10 (8/29/2014)

      • Dividend Declaration Date

      • 7/24/2014

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 60.00

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • 0.96

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 10.00

          • 21.91

          • Net Income

            YTD/YTD (last year)

          • -48.30

          • -5.55

          • Net Income

            Q/Q (last year)

          • 46.00

          • 0.44

          • Sales (Revenue)

            5-Year Annual Average

          • 10.24

          • 47.82

          • Net Income

            5-Year Annual Average

          • 3.40

          • 4.98

          • Dividends

            5-Year Annual Average

          • -

          • 5.31

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 48.86

            • 42.70

            • Pre-Tax Margin

            • 13.84

            • 11.63

            • Net Profit Margin

            • 8.90

            • 9.55

            • Average Gross Margin

              5-Year Annual Average

            • 53.80

            • 43.76

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 16.40

            • 11.34

            • Average Net Profit Margin

              5-Year Annual Average

            • 10.40

            • 52.13B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.00

              • 0.62

              • Current Ratio

              • 7.46

              • 1.23

              • Quick Ratio

              • 5.99

              • 0.76

              • Interest Coverage

              • -

              • 5.98

              • Leverage Ratio

              • 1.15

              • 2.16

              • Book Value/Share

              • 8.75

              • 14.94

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 70.92

                • 32.47

                • P/E Ratio 5-Year High

                • 77.82

                • 325.07

                • P/E Ratio 5-Year Low

                • 25.29

                • 154.73

                • Price/Sales Ratio

                • 6.33

                • 2.26

                • Price/Book Value

                • 5.64

                • 2.95

                • Price/Cash Flow Ratio

                • 33.33

                • 18.55

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 8.32

                    (10.10)

                  • 9.34

                    (9.80)

                  • Return on Assets %

                    (5-Year Average)

                  • 7.30

                    (9.00)

                  • 4.63

                    (5.44)

                  • Return on Capital %

                    (5-Year Average)

                  • 8.30

                    (10.10)

                  • 5.73

                    (6.77)

                  • Income/Employee

                  • 31.92k

                  • 17.17k

                  • Inventory Turnover

                  • 3.27

                  • 5.07

                  • Asset Turnover

                  • 0.82

                  • 0.48

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  20.80M
                  Operating Margin
                  12.10
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  33.33
                  Ownership

                  Institutional Ownership

                  -

                  Top 10 Institutions

                  69.28%

                  Mutual Fund Ownership

                  45.61%

                  Float

                  68.10%

                  5% / Insider Ownership

                  6.11%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Brown Capital Management Small Company

                  •  

                    1,833,580

                  • 0.00

                  • 8.14

                  • PrimeCap Odyssey Aggressive Growth Fund

                  •  

                    1,797,200

                  • -0.22

                  • 8.00

                  • iShares Core S&P Small-Cap (AU)

                  •  

                    422,676

                  • 0.24

                  • 1.79

                  • Vanguard Small Cap Index

                  •  

                    371,729

                  • -0.07

                  • 1.65

                  • iShares Russell 2000 (AU)

                  •  

                    349,175

                  • -1.01

                  • 1.48

                  • Vanguard Total Stock Mkt Idx

                  •  

                    348,230

                  • 0.69

                  • 1.55

                  • Virtus Small-Cap Core Fund

                  •  

                    344,700

                  • 0.00

                  • 1.53

                  • Conestoga Small Cap

                  •  

                    257,000

                  • -18.93

                  • 1.14

                  • Vanguard Small Cap Growth Index Fund

                  •  

                    251,168

                  • -1.83

                  • 1.12

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Brown Capital Management, LLC

                  •  

                    3,488,600

                  • +0.08%

                  • 15.52

                  • Kayne Anderson Rudnick Investment Management LLC

                  •  

                    2,088,508

                  • -0.83%

                  • 9.29

                  • PRIMECAP Management Company

                  •  

                    1,975,700

                  • -0.18%

                  • 8.79

                  • Riverbridge Partners LLC

                  •  

                    1,860,847

                  • +4.56%

                  • 8.28

                  • Vanguard Group, Inc.

                  •  

                    1,436,688

                  • -0.46%

                  • 6.39

                  • Neuberger Berman LLC

                  •  

                    1,436,105

                  • -1.86%

                  • 6.39

                  • BlackRock Fund Advisors

                  •  

                    1,100,927

                  • -6.35%

                  • 4.90

                  • Wasatch Advisors Inc.

                  •  

                    1,082,148

                  • -10.26%

                  • 4.81

                  • Royal Bank Of Canada

                  •  

                    581,366

                  • +4.82%

                  • 2.59

                  • New York State Common Retirement Fund

                  •  

                    521,565

                  • 0.00%

                  • 2.32

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Diagnostics & Research

                  Type

                  Slow Growth

                  Style

                  Small Growth

                  Abaxis Inc is a California corporation and was incorporated in 1989. The Company is a developer, manufacturer and marketer of portable blood analysis systems that are used in medical specialties in human or veterinary patient care to...more provide clinicians with blood constituent measurements. Its products and services include point-of-care diagnostic instruments and consumables used in the medical market, point-of-care diagnostic instruments and consumables used in the veterinary market, and veterinary reference laboratory diagnostic and consulting services for veterinarians provided by Abaxis Veterinary Reference Laboratories (AVRL). The Company manages its business in two reportable business segments, the medical market and the veterinary market, which are based on the diagnostic products sold and ser...morevices provided by market and customer group. For products that it sells that are not specifically identified to any particular business segment, it categorizes the revenue as Other. The Companys products sold to the medical market are used by medical specialties requiring real time results to enable rapid clinical decisions in the area of human diagnostics. Its point-of-care products in the medical market are comprised of its Piccolo chemistry analyzers and consumable products. In the veterinary market, its VetScan products serves a customer group consisting of companion animal hospitals, animal clinics with mixed practices of small animals, birds and reptiles, equine and bovine practitioners, veterinary emergency clinics, veterinary referral hospitals, universities, government, pharmaceutical companies, biotechnology companies and private research laboratories. Its product and service offerings in the veterinary market include VetScan Point-of-Care Blood Chemistry Instruments, VetScan Profiles, Hematology Instruments and Consumables, VSpro Specialty Analyzers and Consumables, i-STAT Instruments and Consumables, Rapid Tests, and Abaxis Veterinary Reference Laboratories services. Its Other segment include sale of products using its patented Orbos Discrete Lyophilization Process (the Orbos process) to companies for other applications. The Orbos process involves flash-freezing a drop of liquid reagent to form a solid bead and then freeze-drying the bead to remove water. The Orbos beads are stable in dry form and dissolve rapidly in aqueous solutions. The dry reagents used in its reagent discs are produced using the Orbos process. This process allows the production of a precise amount of active chemical ingredient in the form of a soluble bead. The Company markets and sells its products worldwide by maintaining direct sales forces and through independent distributors. It competes with Alere, Alfa Wassermann S.P.A., Johnson & Johnson (including its subsidiary, Ortho-Clinical Diagnostics, Inc.), F. Hoffmann-La Roche Ltd, Idexx Laboratories, Inc. and Heska Corporation. The Companys Piccolo products are in vitro diagnostic medical devices subject to regulation by the FDA, under the Federal Food, Drug, and Cosmetic Act (FDCA).lessless

                  Key People

                  Mr. Clinton H. Severson

                  CEO/Chairman of the Board/President/Director

                  Mr. Alberto R. Santa Ines

                  CFO/Chief Accounting Officer/Vice President, Divisional/Secretary

                  Mr. Achim Henkel

                  Managing Director, Subsidiary

                  Craig Tockman

                  Vice President, Divisional

                  Mr. Henk J. Evenhuis

                  Director

                  • Abaxis Inc

                  • 3240 Whipple Road

                  • Union, CA 94587

                  • USA.Map

                  • Phone: +1 510 675-6500

                  • Fax: +1 510 441-6150

                  • abaxis.com

                  Incorporated

                  1989

                  Employees

                  491

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: